Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Biron

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Antimicrobial Agents and Chemotherapy|August 1, 1985
Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolatesJ L Martin, M N Ellis, P M Keller, et al.
Antiviral Research|April 1, 1995
Assays for antiviral drug resistanceD W Kimberlin, S A Spector, E L Hill, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infectionsEarl R Kern, Caroll B Hartline, Rachel J Rybak, et al.
Journal of Medicinal Chemistry|January 1, 1988
Effect of acyclic pyrimidines related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine on herpesvirusesL M Beauchamp, B L Serling, J E Kelsey, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovirT Spector, J A Harrington, R W Morrison, et al.
The Journal of Infectious Diseases|March 1, 1995
Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistanceS Chou, A Erice, M C Jordan, et al.
Journal of Virology|June 28, 2003
The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinasePaula M Krosky, Moon-Chang Baek, Wan Jin Jahng, et al.
Journal of Virology|January 7, 1998
Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene productM R Underwood, R J Harvey, S C Stanat, et al.
The Journal of Infectious Diseases|December 20, 2000
Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitisD A Jabs, B K Martin, M S Forman, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replicationGeorge W Koszalka, Nelson W Johnson, Steven S Good, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Antimicrobial Agents and Chemotherapy|August 1, 1985
Plaque autoradiography assay for the detection and quantitation of thymidine kinase-deficient and thymidine kinase-altered mutants of herpes simplex virus in clinical isolatesJ L Martin, M N Ellis, P M Keller, et al.
Antiviral Research|April 1, 1995
Assays for antiviral drug resistanceD W Kimberlin, S A Spector, E L Hill, et al.
Antimicrobial Agents and Chemotherapy|April 24, 2004
Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infectionsEarl R Kern, Caroll B Hartline, Rachel J Rybak, et al.
Journal of Medicinal Chemistry|January 1, 1988
Effect of acyclic pyrimidines related to 9-[(1,3-dihydroxy-2-propoxy)methyl]guanine on herpesvirusesL M Beauchamp, B L Serling, J E Kelsey, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 1, 1989
2-Acetylpyridine 5-[(dimethylamino)thiocarbonyl]-thiocarbonohydrazone (A1110U), a potent inactivator of ribonucleotide reductases of herpes simplex and varicella-zoster viruses and a potentiator of acyclovirT Spector, J A Harrington, R W Morrison, et al.
The Journal of Infectious Diseases|March 1, 1995
Analysis of the UL97 phosphotransferase coding sequence in clinical cytomegalovirus isolates and identification of mutations conferring ganciclovir resistanceS Chou, A Erice, M C Jordan, et al.
Journal of Virology|June 28, 2003
The human cytomegalovirus UL44 protein is a substrate for the UL97 protein kinasePaula M Krosky, Moon-Chang Baek, Wan Jin Jahng, et al.
Journal of Virology|January 7, 1998
Inhibition of human cytomegalovirus DNA maturation by a benzimidazole ribonucleoside is mediated through the UL89 gene productM R Underwood, R J Harvey, S C Stanat, et al.
The Journal of Infectious Diseases|December 20, 2000
Mutations conferring ganciclovir resistance in a cohort of patients with acquired immunodeficiency syndrome and cytomegalovirus retinitisD A Jabs, B K Martin, M S Forman, et al.
Antimicrobial Agents and Chemotherapy|July 18, 2002
Preclinical and toxicology studies of 1263W94, a potent and selective inhibitor of human cytomegalovirus replicationGeorge W Koszalka, Nelson W Johnson, Steven S Good, et al.
Pageof 8